Renin-Angiotensin-Aldosterone System - Latest Trends consists of five chapters related to the renin-angiotensin-aldosterone system (RAAS). RAAS is a crucial hormonal system that regulates blood pressure, blood volume, and sodium (salt) balance in the body. When the kidneys detect abnormalities in hemodynamics, such as a drop in blood pressure or sodium concentration, renin is secreted, leading to the production of angiotensin II, which is a physiologically active substance. Angiotensin II causes cell proliferation, vasoconstriction, and sodium reabsorption through the angiotensin II type 1 receptor (AT1 receptor), helping maintain hemodynamic balance. Additionally, the AT1 receptor stimulates aldosterone secretion from the adrenal cortex. Aldosterone regulates sodium reabsorption and potassium excretion in the kidneys. Excessive activity of this system can lead to cardiovascular diseases. To address this, RAAS inhibitors such as angiotensin-converting enzyme inhibitors (ACEi), angiotensin II type 1 receptor blockers (ARB), direct renin inhibitors (DRI), and mineralocorticoid receptor antagonists (MRAs), also known as aldosterone blockers, are used to treat hypertension, heart failure, and arteriosclerosis. These therapies can be considered the "20th-century" RAAS inhibitors. In the 21st century, the discovery of the (pro)renin receptor added a new dimension to the RAAS. The physiological activation mechanism following angiotensin II has also been elucidated. While research on the (pro)renin receptor as a RAAS-independent factor with organ-crossing functions and a potential therapeutic target continues, there is still no consensus on its role as part of the RAAS. Further research is needed to explore the physiological activation mechanism following angiotensin II. This book collects the latest research on RAAS, including studies on new indicators related to angiotensin-converting enzyme, and provides valuable information on its functions.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
EUR 4,78 expédition depuis Royaume-Uni vers Etats-Unis
Destinations, frais et délaisVendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L1-9780854668731
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L1-9780854668731
Quantité disponible : Plus de 20 disponibles
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9780854668731_new
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 116 pp. Englisch. N° de réf. du vendeur 9780854668731
Quantité disponible : 2 disponible(s)
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
Etat : New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 422. N° de réf. du vendeur C9780854668731
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Hardcover. Etat : new. Hardcover. Renin-Angiotensin-Aldosterone System - Latest Trends consists of five chapters related to the renin-angiotensin-aldosterone system (RAAS). RAAS is a crucial hormonal system that regulates blood pressure, blood volume, and sodium (salt) balance in the body. When the kidneys detect abnormalities in hemodynamics, such as a drop in blood pressure or sodium concentration, renin is secreted, leading to the production of angiotensin II, which is a physiologically active substance. Angiotensin II causes cell proliferation, vasoconstriction, and sodium reabsorption through the angiotensin II type 1 receptor (AT1 receptor), helping maintain hemodynamic balance. Additionally, the AT1 receptor stimulates aldosterone secretion from the adrenal cortex. Aldosterone regulates sodium reabsorption and potassium excretion in the kidneys. Excessive activity of this system can lead to cardiovascular diseases. To address this, RAAS inhibitors such as angiotensin-converting enzyme inhibitors (ACEi), angiotensin II type 1 receptor blockers (ARB), direct renin inhibitors (DRI), and mineralocorticoid receptor antagonists (MRAs), also known as aldosterone blockers, are used to treat hypertension, heart failure, and arteriosclerosis. These therapies can be considered the "20th-century" RAAS inhibitors. In the 21st century, the discovery of the (pro)renin receptor added a new dimension to the RAAS. The physiological activation mechanism following angiotensin II has also been elucidated. While research on the (pro)renin receptor as a RAAS-independent factor with organ-crossing functions and a potential therapeutic target continues, there is still no consensus on its role as part of the RAAS. Further research is needed to explore the physiological activation mechanism following angiotensin II. This book collects the latest research on RAAS, including studies on new indicators related to angiotensin-converting enzyme, and provides valuable information on its functions. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9780854668731
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Buch. Etat : Neu. Neuware -Renin-Angiotensin-Aldosterone System - Latest Trends consists of five chapters related to the renin-angiotensin-aldosterone system (RAAS). RAAS is a crucial hormonal system that regulates blood pressure, blood volume, and sodium (salt) balance in the body. When the kidneys detect abnormalities in hemodynamics, such as a drop in blood pressure or sodium concentration, renin is secreted, leading to the production of angiotensin II, which is a physiologically active substance. Angiotensin II causes cell proliferation, vasoconstriction, and sodium reabsorption through the angiotensin II type 1 receptor (AT1 receptor), helping maintain hemodynamic balance. Additionally, the AT1 receptor stimulates aldosterone secretion from the adrenal cortex. Aldosterone regulates sodium reabsorption and potassium excretion in the kidneys. Excessive activity of this system can lead to cardiovascular diseases. To address this, RAAS inhibitors such as angiotensin-converting enzyme inhibitors (ACEi), angiotensin II type 1 receptor blockers (ARB), direct renin inhibitors (DRI), and mineralocorticoid receptor antagonists (MRAs), also known as aldosterone blockers, are used to treat hypertension, heart failure, and arteriosclerosis. These therapies can be considered the '20th-century' RAAS inhibitors. In the 21st century, the discovery of the (pro)renin receptor added a new dimension to the RAAS. The physiological activation mechanism following angiotensin II has also been elucidated. While research on the (pro)renin receptor as a RAAS-independent factor with organ-crossing functions and a potential therapeutic target continues, there is still no consensus on its role as part of the RAAS. Further research is needed to explore the physiological activation mechanism following angiotensin II. This book collects the latest research on RAAS, including studies on new indicators related to angiotensin-converting enzyme, and provides valuable information on its functions.Books on Demand GmbH, Überseering 33, 22297 Hamburg 116 pp. Englisch. N° de réf. du vendeur 9780854668731
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering. N° de réf. du vendeur 9780854668731
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Buch. Etat : Neu. Renin-Angiotensin-Aldosterone System - Latest Trends | Latest Trends | Takaaki Senbonmatsu (u. a.) | Buch | Englisch | 2025 | IntechOpen | EAN 9780854668731 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 132546609
Quantité disponible : 5 disponible(s)